Better Buy: Amgen vs. Bristol Myers Squibb
Amgen (NASDAQ: AMGN) and Bristol Myers Squibb (NYSE: BMY) share quite a few things in common. Both, of course, are big drugmakers with several successful products on the market. They’re nearly exactly the same size in terms of market cap. Both Amgen and BMS have delivered disappointing returns for investors so far this year.
Which stock is the better pick going forward? Here’s how Amgen and BMS compare in four key areas.
Image source: Getty Images.